Page 2 - Pharamaceutical Industries

Govt focussing on production of high-value pharmaceuticals: Health Minister

The government is taking steps to produce "high value pharmaceuticals" in the country to reduce import dependency for such critical articles, Union Minister Mansukh Mandaviya said on Tuesday. Manufacturing of components of high-end medical devices in the country will be another big step in moving towards self reliance, the Union Minister for Chemicals and Fertilisers noted. "Working on the vision of reducing import dependency through indigenous production, the government is focussing on production of high value pharmaceuticals and high-end medical devices," he said. Mandaviya said the Department of Pharmaceuticals (DoP) has released the first tranche of incentives under the Product Linked Incentive (PLI) scheme of pharmaceuticals amounting to Rs 166 crore to four selected applicants. Under the Atmanirbharta initiative of the government, DoP launched the PLI scheme for pharmaceuticals in 2021. The financial outlay under this PLI scheme is Rs 15,000 crore over a period of six years.

India's Laurus Labs posts 32% profit jump on demand for drug ingredients

India's Laurus Labs Ltd reported a 32.1% rise in third-quarter profit on Monday, boosted by strong demand in its businesses that make chemicals and other ingredients used in medicines

Glenmark Life Sciences profit rises 1% in Dec quarter on API strength

The Mumbai-based drug maker's profit rose to 1.05 billion rupees ($12.86 million) in the three months ended Dec. 31, from 1.04 billion rupees a year ago

Gland Pharma to acquire French firm Cenexi Group for Rs 1,000 crore

Will fund transaction from internal accruals

Top 300 drug brands to now have QR codes on label for ensuring authenticity

Govt finalises the draft notification issued in June

Pharma marketing practices: High-level committee to meet industry on Friday

The UCPMP is voluntary and there is no legal penalty for violating the code

Wockhardt likely to sell India business to cut debt, focus on UK: Analysts

Company left with low-margin brands in India after selling profitable ones

Govt launches diabetes drug Sitagliptin, its combinations at Rs 60 per pack

The government on Friday launched diabetes drug Sitagliptin and its combinations at rates as low as Rs 60 per pack of ten, which will be sold at generic pharmacy stores, Janaushadhi Kendras. The Pharmaceuticals & Medical Devices Bureau of India (PMBI) has included new variants of Sitagliptin and its combination across its Jan Aushdhi Kendras, the Ministry of Chemicals and Fertilisers said in a statement. The maximum retail price for a pack of ten Sitagliptin phosphate tablets 50 mg is Rs 60, while the same for Sitagliptin phosphate tablet 100 mg is Rs 100. Combination of Sitagliptin and Metformin Hydrochloride tablets of 50mg/500mg is priced at Rs 65 for a pack of ten and Sitagliptin Metformin hydrochloride tablets of 50mg/1000mg strength comes for Rs 70 for the same quantity. "All these variants are available at 60 per cent to 70 per cent lesser prices than branded variants as they are available in price band of Rs 162 to Rs 258 at other medical stores," the statement said. PMBI

The pink of health: Trade generics now key growth driver for Cipla

Vertical witnesses 25% CAGR in 5 yrs

Bharat Biotech says Phase 3 trial over, intranasal vaccine 'safe'

The Hyderabad-based company claimed that BBV154 is proven to be safe, well-tolerated and immunogenic in the subjects under controlled clinical trials

AP EAMCET Agriculture 2022 answer key released- here's how you can check

More than 200,000 candidates appeared for the AP EAPCET exam this year

AIMIL Pharma launches ayurveda-based beauty product

The product -- Ayouthveda -- has been prepared by adding time-tested herbs

Dr Reddy's Lab receives USFDA approval to market Lenalidomide capsule

Dr Reddy's Laboratories on Tuesday said it has received approval from the US health regulator to market Lenalidomide capsules

Over 300 pharma, healthcare companies eligible for new Covid loans: Crisil

Hospitals to gain most with up to 3.5% dip on cost of funds; may add half a million beds, says rating agency

Companies announce clinical trials for vaccine against China virus

At least four companies say they are working 'very rapidly' to find a vaccine.

From Zinetac to Calpol, top 10 drugs drive India revenue for big firms

Experts expect change in strategy for a focus on high-margin products, rather than multiple brand launches

The cost of cheap drugs? Toxic Indian lake is 'superbug hotspot'

Drugmakers in Medak, including large Indian firms Dr Reddy's Laboratories, Aurobindo Pharma and Hetero Drugs

Pharma sector raises concerns over proposed incentives cut

Union government is allegedly cutting down support to bulk drug manufacturing from a proposed outlay of Rs 5,000 crore to nearly Rs 600 crore